Related Experiment Video
Updated: Feb 23, 2026
04:16
Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants
Published on: August 5, 2021
2.8K
A facile novel fluorocarbon copolymer solution coating process for improving platelet compatibility of titanium
Sophia Chao-Wei Huang1, Chi-Hui Cheng2, Yun Chiu1
1Department of Chemical Engineering, National Cheng Kung University, Tainan 70101, Taiwan.
Summary
This study developed a novel copolymer coating for titanium (Ti) surfaces to reduce blood clot formation. The modified Ti surfaces showed significantly lower platelet adhesion and activation, improving biocompatibility for biomedical uses.
Area of Science:
- Biomaterials Science
- Surface Chemistry
- Biomedical Engineering
Background:
- Titanium (Ti) and its alloys are widely used in biomedical applications due to their excellent mechanical properties and biocompatible oxide layer.
- However, Ti surfaces can trigger adverse bioreactions like platelet adhesion and activation, leading to thrombotic complications.
- Surface modification with fluorocarbons can mitigate these issues, but direct deposition is technically challenging.
Purpose of the Study:
- To develop a facile method for modifying titanium surfaces to reduce thrombogenicity and improve biocompatibility.
- To synthesize and utilize novel copolymers of 2,2,2-trifluoroethyl methacrylate (TFEMA) and vinylphosphonic acid (VPA) for titanium surface modification.
- To evaluate the efficacy of these modified surfaces in reducing platelet adhesion, activation, and ensuring cytocompatibility.
Main Methods:
- Synthesized copolymers of TFEMA and VPA via free radical polymerization.
- Modified titanium substrates using a facile coating process with the synthesized copolymers.
- Characterized the modified surfaces using Nuclear Magnetic Resonance (NMR) and X-ray Photoelectron Spectroscopy (XPS).
- Assessed in vitro platelet adhesion and activation.
- Performed in vitro cytotoxicity assays.
Main Results:
- Confirmed copolymer synthesis and successful modification of titanium substrates via NMR and XPS.
- Demonstrated significantly reduced platelet adhesion and activation on specific copolymer-modified titanium surfaces.
- Exhibited no induced cytotoxicity on the modified titanium surfaces.
Conclusions:
- Novel copolymers of TFEMA and VPA can be effectively used to modify titanium surfaces via a facile coating process.
- The modified titanium surfaces exhibit lower surface energy and higher hydrophobicity, significantly reducing thrombus formation.
- These modifications enhance the biocompatibility of titanium for biomedical applications without inducing cytotoxicity.
